XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.25.3

Segments | 9 Months Ended
--- | ---
Sep. 30, 2025
Segments [Abstract] |
Segments | 3. Segments Our segment s include the VITAS segment and the Roto-Rooter segment, which comprise the structure used by our President and Chief Executive Officer, who has been determined to be our Chief Operating Decision Maker (“CODM”) to make key operating decisions and assess performance. Relative contributions of each segment to service revenues and sales for the third quarter of 2025 and 2024 were 65% and 35%. Relative contributions of each segment to service revenues and sales for the first nine months of 2025 were 64% and 36% compared to the first nine months of 2024 were 63% and 37%. The vast majority of our service revenues and sales from continuing operations are generated from business within the United States. Service revenues and sales by business segment are shown in Note 2. The reportable segments have been defined along service lines, which is consistent with the way the businesses are managed. In determining reportable segments, the RRSC and RRC operating units of the Roto-Rooter segment have been aggregated on the basis of possessing similar operating and economic characteristics. The characteristics of these operating segments and the basis for aggregation are reviewed annually. We report corporate administrative expenses and unallocated investing and financing income and expense not directly related to either segment as “Corporate”. Corporate administrative expense includes the stewardship, accounting and reporting, legal, tax and other costs of operating a publicly held corporation. Corporate investing and financing income and expenses include the costs and income associated with corporate debt and investment arrangements. Our CODM evaluates the segments’ operating performance based mainly on income/(loss) from operations. For each segment, the CODM compares segment income/(loss) from operations in the annual budgeting and monthly forecasting process to actual results. The CODM considers variances on a monthly basis for evaluating performance of each segment and making decisions about allocating resources to each segment. ‎ Segment data for the three months ending September 30, 2025 are as follows (in thousands):
|  |  |  |  |  |  |  | Reportable |  |  |  |  | Chemed
|  | VITAS |  | Roto-Rooter |  | Segments |  | Corporate |  | Consolidated
Service revenues and sales |  | $ | 407,741 |  | $ | 217,159 |  | $ | 624,900 |  | $ | - |  | $ | 624,900
Cost of services provided and goods sold |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(excluding depreciation) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages |  |  | 239,357 |  |  | 72,992 |  |  | 312,349 |  |  | - |  |  | 312,349
Patient care expense |  |  | 43,269 |  |  | - |  |  | 43,269 |  |  | - |  |  | 43,269
Other expenses |  |  | 38,239 |  |  | 34,136 |  |  | 72,375 |  |  | - |  |  | 72,375
Total cost of services provided and goods sold |  |  | 320,865 |  |  | 107,128 |  |  | 427,993 |  |  | - |  |  | 427,993
Selling, general and administrative expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages |  |  | 16,904 |  |  | 21,122 |  |  | 38,026 |  |  | 6,440 |  |  | 44,466
Advertising |  |  | - |  |  | 19,542 |  |  | 19,542 |  |  | - |  |  | 19,542
Stock compensation |  |  | - |  |  | - |  |  | - |  |  | 5,851 |  |  | 5,851
Other expenses |  |  | 8,332 |  |  | 20,008 |  |  | 28,340 |  |  | 7,576 |  |  | 35,916
Total selling, general and administrative expense |  |  | 25,236 |  |  | 60,672 |  |  | 85,908 |  |  | 19,867 |  |  | 105,775
Depreciation |  |  | 5,354 |  |  | 8,298 |  |  | 13,652 |  |  | 12 |  |  | 13,664
Amortization |  |  | 26 |  |  | 2,544 |  |  | 2,570 |  |  | - |  |  | 2,570
Other operating expense/(income) |  |  | 186 |  |  | (38) |  |  | 148 |  |  | - |  |  | 148
Total costs and expenses |  |  | 351,667 |  |  | 178,604 |  |  | 530,271 |  |  | 19,879 |  |  | 550,150
Income/(loss) from operations |  |  | 56,074 |  |  | 38,555 |  |  | 94,629 |  |  | (19,879) |  |  | 74,750
Interest expense |  |  | (56) |  |  | (132) |  |  | (188) |  |  | (269) |  |  | (457)
Intercompany interest income/(expense) |  |  | 5,685 |  |  | 4,030 |  |  | 9,715 |  |  | (9,715) |  |  | -
Other income - net |  |  | 61 |  |  | 25 |  |  | 86 |  |  | 9,165 |  |  | 9,251
Income/(expense) before income taxes |  |  | 61,764 |  |  | 42,478 |  |  | 104,242 |  |  | (20,698) |  |  | 83,544
Income taxes |  |  | (14,993) |  |  | (10,407) |  |  | (25,400) |  |  | 6,093 |  |  | (19,307)
Net income/(loss) |  | $ | 46,771 |  | $ | 32,071 |  | $ | 78,842 |  | $ | (14,605) |  | $ | 64,237
Additions to long-lived assets |  | $ | 10,850 |  | $ | 6,639 |  | $ | 17,489 |  | $ | 10 |  | $ | 17,499
‎ Segment data for the three months September 30, 2024 are as follows (in thousands):
|  |  |  |  |  |  |  | Reportable |  |  |  |  | Chemed
|  | VITAS |  | Roto-Rooter |  | Segments |  | Corporate |  | Consolidated
Service revenues and sales |  | $ | 391,406 |  | $ | 214,775 |  | $ | 606,181 |  | $ | - |  | $ | 606,181
Cost of services provided and goods sold |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(excluding depreciation) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages |  |  | 222,868 |  |  | 70,078 |  |  | 292,946 |  |  | - |  |  | 292,946
Patient care expense |  |  | 37,188 |  |  | - |  |  | 37,188 |  |  | - |  |  | 37,188
Other expenses |  |  | 34,880 |  |  | 31,173 |  |  | 66,053 |  |  | - |  |  | 66,053
Total cost of services provided and good sold |  |  | 294,936 |  |  | 101,251 |  |  | 396,187 |  |  | - |  |  | 396,187
Selling, general and administrative expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages |  |  | 17,658 |  |  | 18,979 |  |  | 36,637 |  |  | 3,643 |  |  | 40,280
Advertising |  |  | - |  |  | 18,420 |  |  | 18,420 |  |  | - |  |  | 18,420
Stock compensation |  |  | - |  |  | - |  |  | - |  |  | 9,121 |  |  | 9,121
Other expenses |  |  | 8,225 |  |  | 19,673 |  |  | 27,898 |  |  | 6,262 |  |  | 34,160
Total selling, general and administrative expense |  |  | 25,883 |  |  | 57,072 |  |  | 82,955 |  |  | 19,026 |  |  | 101,981
Depreciation |  |  | 5,063 |  |  | 8,071 |  |  | 13,134 |  |  | 13 |  |  | 13,147
Amortization |  |  | 26 |  |  | 2,524 |  |  | 2,550 |  |  | - |  |  | 2,550
Other operating expense/(income) |  |  | 97 |  |  | 62 |  |  | 159 |  |  | - |  |  | 159
Total costs and expenses |  |  | 326,005 |  |  | 168,980 |  |  | 494,985 |  |  | 19,039 |  |  | 514,024
Income/(loss) from operations |  |  | 65,401 |  |  | 45,795 |  |  | 111,196 |  |  | (19,039) |  |  | 92,157
Interest expense |  |  | (46) |  |  | (114) |  |  | (160) |  |  | (267) |  |  | (427)
Intercompany interest income/(expense) |  |  | 4,920 |  |  | 3,656 |  |  | 8,576 |  |  | (8,576) |  |  | -
Other income - net |  |  | 62 |  |  | 18 |  |  | 80 |  |  | 9,219 |  |  | 9,299
Income/(expense) before income taxes |  |  | 70,337 |  |  | 49,355 |  |  | 119,692 |  |  | (18,663) |  |  | 101,029
Income taxes |  |  | (16,851) |  |  | (11,400) |  |  | (28,251) |  |  | 2,998 |  |  | (25,253)
Net income/(loss) |  | $ | 53,486 |  | $ | 37,955 |  | $ | 91,441 |  | $ | (15,665) |  | $ | 75,776
Additions to long-lived assets |  | $ | 7,768 |  | $ | 10,778 |  | $ | 18,546 |  | $ | 100 |  | $ | 18,646
‎ Segment data for the nine months September 30, 2025 are as follows (in thousands):
|  |  |  |  |  |  |  | Reportable |  |  |  |  | Chemed
|  | VITAS |  | Roto-Rooter |  | Segments |  | Corporate |  | Consolidated
Service revenues and sales |  | $ | 1,211,341 |  | $ | 679,300 |  | $ | 1,890,641 |  | $ | - |  | $ | 1,890,641
Cost of services provided and goods sold |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(excluding depreciation) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages |  |  | 716,335 |  |  | 226,168 |  |  | 942,503 |  |  | - |  |  | 942,503
Patient care expense |  |  | 124,656 |  |  | - |  |  | 124,656 |  |  | - |  |  | 124,656
Other expenses |  |  | 113,325 |  |  | 112,144 |  |  | 225,469 |  |  | - |  |  | 225,469
Total cost of services provided and goods sold |  |  | 954,316 |  |  | 338,312 |  |  | 1,292,628 |  |  | - |  |  | 1,292,628
Selling, general and administrative expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages |  |  | 51,188 |  |  | 63,326 |  |  | 114,514 |  |  | 13,919 |  |  | 128,433
Advertising |  |  | - |  |  | 56,654 |  |  | 56,654 |  |  | - |  |  | 56,654
Stock compensation |  |  | - |  |  | - |  |  | - |  |  | 27,668 |  |  | 27,668
Other expenses |  |  | 25,673 |  |  | 63,876 |  |  | 89,549 |  |  | 9,381 |  |  | 98,930
Total selling, general and administrative expense |  |  | 76,861 |  |  | 183,856 |  |  | 260,717 |  |  | 50,968 |  |  | 311,685
Depreciation |  |  | 15,863 |  |  | 24,899 |  |  | 40,762 |  |  | 36 |  |  | 40,798
Amortization |  |  | 78 |  |  | 7,635 |  |  | 7,713 |  |  | - |  |  | 7,713
Other operating expense/(income) |  |  | 305 |  |  | (80) |  |  | 225 |  |  | - |  |  | 225
Total costs and expenses |  |  | 1,047,423 |  |  | 554,622 |  |  | 1,602,045 |  |  | 51,004 |  |  | 1,653,049
Income/(loss) from operations |  |  | 163,918 |  |  | 124,678 |  |  | 288,596 |  |  | (51,004) |  |  | 237,592
Interest expense |  |  | (150) |  |  | (394) |  |  | (544) |  |  | (685) |  |  | (1,229)
Intercompany interest income/(expense) |  |  | 16,436 |  |  | 11,930 |  |  | 28,366 |  |  | (28,366) |  |  | -
Other income - net |  |  | 170 |  |  | 58 |  |  | 228 |  |  | 13,742 |  |  | 13,970
Income/(expense) before income taxes |  |  | 180,374 |  |  | 136,272 |  |  | 316,646 |  |  | (66,313) |  |  | 250,333
Income taxes |  |  | (45,353) |  |  | (32,344) |  |  | (77,697) |  |  | 15,851 |  |  | (61,846)
Net income/(loss) |  | $ | 135,021 |  | $ | 103,928 |  | $ | 238,949 |  | $ | (50,462) |  | $ | 188,487
Additions to long-lived assets |  | $ | 22,234 |  | $ | 24,825 |  | $ | 47,059 |  | $ | 15 |  | $ | 47,074
‎ Segment data for the nine months September 30, 2024 are as follows (in thousands):
|  |  |  |  |  |  |  | Reportable |  |  |  |  | Chemed
|  | VITAS |  | Roto-Rooter |  | Segments |  | Corporate |  | Consolidated
Service revenues and sales |  | $ | 1,119,970 |  | $ | 671,324 |  | $ | 1,791,294 |  | $ | - |  | $ | 1,791,294
Cost of services provided and goods sold |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(excluding depreciation) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages |  |  | 639,103 |  |  | 221,669 |  |  | 860,772 |  |  | - |  |  | 860,772
Patient care expense |  |  | 108,887 |  |  | - |  |  | 108,887 |  |  | - |  |  | 108,887
Other expenses |  |  | 104,357 |  |  | 97,048 |  |  | 201,405 |  |  | - |  |  | 201,405
Total cost of services provided and goods sold |  |  | 852,347 |  |  | 318,717 |  |  | 1,171,064 |  |  | - |  |  | 1,171,064
Selling, general and administrative expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages |  |  | 51,556 |  |  | 60,056 |  |  | 111,612 |  |  | 11,950 |  |  | 123,562
Advertising |  |  | - |  |  | 55,271 |  |  | 55,271 |  |  | - |  |  | 55,271
Stock compensation |  |  | - |  |  | - |  |  | - |  |  | 39,730 |  |  | 39,730
Other expenses |  |  | 22,412 |  |  | 60,356 |  |  | 82,768 |  |  | 18,778 |  |  | 101,546
Total selling, general and administrative expense |  |  | 73,968 |  |  | 175,683 |  |  | 249,651 |  |  | 70,458 |  |  | 320,109
Depreciation |  |  | 15,288 |  |  | 24,275 |  |  | 39,563 |  |  | 38 |  |  | 39,601
Amortization |  |  | 79 |  |  | 7,538 |  |  | 7,617 |  |  | - |  |  | 7,617
Other operating expense |  |  | 160 |  |  | 128 |  |  | 288 |  |  | - |  |  | 288
Total costs and expenses |  |  | 941,842 |  |  | 526,341 |  |  | 1,468,183 |  |  | 70,496 |  |  | 1,538,679
Income/(loss) from operations |  |  | 178,128 |  |  | 144,983 |  |  | 323,111 |  |  | (70,496) |  |  | 252,615
Interest expense |  |  | (138) |  |  | (349) |  |  | (487) |  |  | (794) |  |  | (1,281)
Intercompany interest income/(expense) |  |  | 15,096 |  |  | 10,638 |  |  | 25,734 |  |  | (25,734) |  |  | -
Other income - net |  |  | 138 |  |  | 64 |  |  | 202 |  |  | 27,806 |  |  | 28,008
Income/(expense) before income taxes |  |  | 193,224 |  |  | 155,336 |  |  | 348,560 |  |  | (69,218) |  |  | 279,342
Income taxes |  |  | (46,517) |  |  | (36,010) |  |  | (82,527) |  |  | 14,865 |  |  | (67,662)
Net income/(loss) |  | $ | 146,707 |  | $ | 119,326 |  | $ | 266,033 |  | $ | (54,353) |  | $ | 211,680
Additions to long-lived assets |  | $ | 104,337 |  | $ | 29,800 |  | $ | 134,137 |  | $ | 271 |  | $ | 134,408
Identifiable assets by segment are as follows (in thousands):
| September 30, |  | December 31,
| 2025 |  | 2024
VITAS | $ | 822,484 |  | $ | 839,568
Roto-Rooter |  | 535,182 |  |  | 529,076
Reportable segments |  | 1,357,666 |  |  | 1,368,644
Corporate |  | 265,953 |  |  | 299,931
Chemed consolidated | $ | 1,623,619 |  | $ | 1,668,575

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 9: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 10: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration